n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Ischemic Attack, Transient in 2 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunz, A | 1 |
| Abe, T | 1 |
| Hochrainer, K | 1 |
| Shimamura, M | 1 |
| Anrather, J | 1 |
| Racchumi, G | 1 |
| Zhou, P | 1 |
| Iadecola, C | 1 |
| Hara, K | 1 |
| Kong, DL | 1 |
| Sharp, FR | 1 |
| Weinstein, PR | 1 |
2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Ischemic Attack, Transient
| Article | Year |
|---|---|
Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.
Topics: Amino Acid Sequence; Animals; CD36 Antigens; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Encephal | 2008 |
Effect of selective inhibition of cyclooxygenase 2 on temporary focal cerebral ischemia in rats.
Topics: Animals; Brain; Cerebral Infarction; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase I | 1998 |